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Abstract
Cheese whey (CW) is the yellow-green liquid main by-product from cheese 
manufacturing. Historically, it has been recognized as a major environmental pol-
lutant. Nowadays, it represents a source of high-quality nutrients, such as lactose. 
Enzymatic bioprocesses, chemical synthetic reactions and microbial bioprocesses 
use lactose as substrate to obtain relevant derivatives such as lactitol, lactulose, lac-
tosucrose, sialyllactose, kefiran and galacto-oligosaccharides. These lactose deriva-
tives stimulate the growth of indigenous bifidobacteria and lactobacilli improving 
the intestinal motility, enhancing immunity and promoting the synthesis of 
vitamins. Also, they have versatile applications in pharmaceutical, biotechnological 
and food industries. Therefore, this book chapter shows the state of the art focusing 
on recent uses of CW lactose to produce value-added functional compounds and 
discusses new insights associated with their human health-promoting effects and 
well-being.
Keywords: cheese whey, bioprocesses, value-added functional compounds, lactose, 
kefiran
1. Introduction
Cheese whey (CW) is the yellow-green liquid main by-product from the 
manufacture of cheese [1]. “Serum milk” remaining after the precipitation and 
removal of milk proteins by proteolytic enzymes or acid may also be defined as 
CW [2]. Industrial cheese manufacturing processes produce sweet or acid whey 
(Figure 1). Normally, the production of 1 kg of cheese requires 10 kg of milk 
originating 9 kg of CW [3, 4]. Worldwide cheese production was estimated by 
FAO (Food and Agricultural Organization) at 22.65 M tons in 2014 [5]. Therefore, 
CW is estimated at 203.9 M tons. Besides, the global growth rate of it is parallel 
to the cheese production and it has been calculated about 2% per annum [6]. This 
amount represents a challenge difficult to deal with.
Previous studies have reported high quantity of organic matter in CW [7]. The 
chemical composition of it is shown in Table 1. This by-product has 50, 000–102, 
000 mg/L Chemical Oxygen Demand (COD) and 27, 000–60, 000 mg/L Biological 
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Figure 1. 
Overview of value-added functional compounds using lactose from cheese whey as substrate.
Chemical composition (g/100 g)
Cheese whey type Total solids Lactose Protein Fat Ash
Sweet cheese whey 6.7 4.8 0.6 0.25 0.54
Sweet cheese whey permeate 5.5 4.7 0.05 <0.01 0.51
Acid cheese whey 5.1 4.4 0.73 0.05 0.6
Acid cheese whey pemeate 5.8 4.3 0.06 <0.01 0.56
Table 1. 
Chemical composition of different types of cheese whey.
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Oxygen Demand (BOD) [7]. Due to its high BOD, CW presents 175-fold higher 
organic load than typical sewage effluents [6]. Lactose (4-O-ß-D-galactopyranosyl-
D-glucose) is one of the main CW components. It causes about 90% of COD and 
BOD [8]. Moreover, CW represents about 85–95% of the milk volume. This amount 
has been partially land spreading, disposal to natural water bodies or municipal sewer 
systems [2–4]. Consequently, it is considered a major pollutant to the environment.
On the other hand, CW is a liquid with high nutritional content [9]. It retains 
about 55% of the milk nutrients such as lactose, whey proteins, lipids, vitamins 
and minerals (Table 1). The chemical make-up of it can vary depending on the 
animal species from which milk was obtained [1]. It has been reported that about 
50% of the total CW worldwide production is used it [10]. Animal feeding or as 
an ingredient in therapeutic formulations and food applications are common CW 
uses [11, 12]. Several technological approaches have been developed to transform it 
into value-added compounds reducing the environmental impact. CW processing 
is carried out directly by physical or thermal treatments to obtain protein isolate 
(WPI), whey protein concentrate (WPC), whey protein hydrolysates, whey perme-
ate, lactose and other fractions. Indirectly, CW is used as substrate for enzymatic/
microbial bioprocesses to produce biogas, bioethanol, bioprotein, biopolymers, 
flavors and organic acids among others [11, 13]. Thus, it is an excellent substrate 
for physical treatments, enzymatic catalysis and metabolic microbial reactions that 
could be exploited by the medical, agri-food and biotechnology industries [6].
CW is a source of functional proteins, peptides, lipids and carbohydrates. This 
by-product is the main source of lactose manufactured on an industrial scale, as well as 
a low-cost substrate able to reduce high production costs. This disaccharide (C12H22O11) 
is the most abundant in CW representing around 70–72% (w/w) of the total solids 
[14]. The manufacture of edible lactose includes physical treatments such as ultrafiltra-
tion, nanofiltration, concentration, crystallization, washed and dried [15]. Lactose is 
a valuable ingredient used in a wide variety of products, such as bread, supplement in 
baby milk formulae, confectionaries and excipients for pharmaceutical products [16].
The use of lactose as raw material is a key point to several industrial and labora-
tory transformation processes. This disaccharide represents an ideal substrate to 
obtain relevant lactose derivatives associated with health-promoting benefits. For 
example, lactulose (C12H22O11; 4-O-ß-D-galactopyranosyl-ß- D-fructofuranose), 
which is synthetized by chemical isomerization, is a typical prebiotic as bifidus 
factor added to infant formulae [16].
Enzymatic catalytic and fermentation bioprocesses also use CW lactose as 
substrate to produce important value-added functional compounds [16, 17]. 
Kefiran, organic acids, lactosucrose and galacto-oligosaccharides (GOS) are some of 
the most representative compounds able to improve human health and well-being 
(Figure 1). For instance, GOS [Gal-(Gal)n-Glu] that are produced by enzymatic 
polymerization using ß-galactosidase, improve gut health. Besides, exopolysaccha-
rides such as kefiran are synthetized by the fermenting bioprocesses of lactic acid 
bacteria [16, 18]. Therefore, this chapter discusses recent uses of lactose from CW to 
produce value-added functional compounds. New insights associated with human 
health benefits of these compounds are explored.
2. Lactose derivatives with health benefits
2.1 Lactitol
Lactitol is a lactose-derived compound defined as synthetic sugar alcohol 
(C12H24O11; 4-O-ß-D-galactopyranosyl-D-glucitol; molecular weight (MW), 
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344.31 g/mol) comprising galactose (D-Gal) and D-sorbitol. This compound 
is synthetized by catalytic hydrogenation reactions using lactose as substrate. 
Industrially, this chemical process is based on the addition of molecular hydrogen 
to the carbonyl group of the glucose molecules. This chemical reaction needs 
110°-150°C temperature, 20–70 bars of hydrogen gas pressure, as well as 1.5–10% 
Ni, Pd or Ru transition metals in either carbon or alumina. Lactitol is the primary 
reaction product with reaction yields of >90%. This polyol has been used in the 
food industry as a relevant ingredient in desserts, bakery products, chewing gums, 
chocolate and confectionary products. One of the advantages of lactitol used as 
sweetener is that it can be metabolized by saccharolytic bacteria providing only 
2 kcal/g. It also exerts properties such as cryoprotectant, dryoprotectant, stabilizer 
agent, hydrogel delivering bioactive compounds and additive for the development 
of biosensors [19].
Several human health benefits have been associated to lactitol intake. Clinical 
trials have demonstrated positive gastrointestinal health benefits of this polyol [20]. 
A random-effect meta-analysis of lactitol supplementation on adult constipation 
demonstrated favorable efficacy and tolerance when it was compared to stimu-
lant laxatives and placebo. Lactitol was able to induce increased fecal volume by 
stimulating peristalsis [21]. In fact, lactitol is one of the most frequently prescribed 
osmotic laxative agents to treat constipation [22]. Investigations performed on the 
effectiveness of lactitol for treatment of several types of hepatic encephalopathy in 
infants, children and elderly subjects have demonstrated positive results. Actually, 
lactitol is recommended as a first-line treatment for hepatic encephalopathy as a 
result of decreasing the absorption and production of ammonia and reducing the 
intestinal pH [23, 24]. Indeed, in the last years advances in the field of nanomedi-
cine had led to the development of polylactitol as a multifunctional carrier for liver 
cancer therapy [24].
Lactitol is a non-digestible carbohydrate with prebiotic effect. Prebiotic is a 
substrate that is selectively utilized by host microorganisms conferring a health 
benefit [25]. Previous studies have reported relevant lactitol symbiotic effects. 
Medical practitioners frequently recommend them as therapeutics. Recently, it was 
demonstrated that the consumption of the symbiotic combination with this lactose-
derived prebiotic, Bifidobacterium bifidum and Lactobacillus acidophilus was able 
to eradicate OXA-48-producing Enterobacteriaceae. The measure of this metabolite 
is used as prophylaxis to prevent intestinal translocations in neutropenic patients 
and for the prevention of pneumonia [26]. Also, the symbiotic supplementation 
on the gut microbiota of healthy elderly volunteers with Lactobacillus acidophilus 
NCFM and lactitol improved their health status modifying the intestinal environ-
ment and the microbiota composition. It was observed an increasing lactobacilli 
and bifidobacteria and a possible stabilizing effect on Blautia coccoides-Eubacterium 
rectale and Clostridium cluster XIV levels [27]. Even though the Federal and Drug 
Administration (FDA) agency categorized lactose-derived prebiotic as “GRAS” 
(Generally Recognized as Safe), the excess consumption has adverse effects such as 
osmotic diarrhea, abdominal pain and vomiting [20]. It has been reported that the 
maximum permissive dosage of lactitol for Japanese adults not to induce transitory 
diarrhea was 0.36 g/kg of body weight [28]. It was also found that the dose of this 
lactose-derived prebiotic treatment is age- and case-dependent [20].
2.2 Lactulose
Lactulose is a semi-synthetic disaccharide (C12H22O11; 4-O-ß-D-
galactopyranosyl-ß-D-fructofuranose; MW, 342.30 g/mol) comprising D-galactose 
(D-Gal) and D-fructose (D-Fru) linked by ß-1-4 glycosidic bond [16, 29]. 
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Commercially, this artificial disaccharide is synthetized by alkaline isomerization 
of lactose via the Lobry de Bruyn e Alberda van Ekenstein rearrangement in which 
the D-glucose unit at the reducing end of the lactose molecule is converted to 
D-fructose. The maximum yield of lactulose relative to initial lactose concentration 
adding complexing agents may reach up to 88% [30]. Electro-activation is a novel 
eco-friendly technology able to synthetize lactulose from CW-lactose at maximum 
yield of 35% [31]. In the last decade lactulose has been synthetized at lab scale 
using lactose as substrate by the transgalactosylation activity of ß-glucosidase [29]. 
This disaccharide is formed in milk during heat treatments also, so pasteurized 
milk usually has <100 mg/L lactulose content, meanwhile ultra-high  temperature 
(UHT) milk generally has a lactulose content over 500 mg/L [32]. Actually, 
this polyol has demonstrated versatile applications in pharmaceutical and food 
industries. Lactulose can be found as relevant functional ingredient of infant food 
formulae, fermented dairy products, bakery products, confectionary products and 
soy milk [33, 34].
Previous studies have reported remarkable health benefits associated to lactulose 
consumption. In fact, this disaccharide is used in clinical practice since 1957. This 
disaccharide is lactose-derived prebiotic able to prevent and to treat diseases [35]. 
Lactulose is only metabolized by specific species of colonic microbiota through 
ß-glucosidase activity altering the microbial balance by increasing the probiotic 
growth and reducing putrefactive bacteria. Consequently, lowering intestinal 
pH, enhanced colonic motility, reduced concentration of ammonia and improved 
absorption of minerals are also benefits of the physiological action of lactulose upon 
bacterial metabolism in the large intestine [30].
In silico, in vitro and in vivo studies have demonstrated the efficacy of lactulose 
in the treatment of several diseases [35]. Since the 1960s, patients of all ages have 
been prescribed with lactulose to treat constipation, even if it is chronic. This 
lactose-derived prebiotic is an osmotic laxative [33]. The effect of lactulose was 
studied in healthy volunteers. A significant increase of Bifidocaterium, Lactobacillus 
and Streptococcus was reached, meanwhile the population of coliforms, Bacteroides, 
Clostridium and Eubacterium was significantly decreased. These changes in the 
microbiota reduced activity of pro-carcinogenic enzymes, increased short-chain 
fatty acids in feces and pH decreased [36]. Clinical trials also have reported favor-
able results using lactulose to treat hepatic encephalopathy and chronic kidney 
disease [30]. Recently, the prebiotic effect of lactitol, raffinose, oligofructose and 
lactulose was evaluated on Lactobacillus spp. and bacterial vaginosis-associated 
organisms (BV) and Candida albicans. Results showed that lactulose had the most 
broadly and specifically growth stimulation on vaginal lactobacilli and did not to 
stimulate BV or Candida albicans [37]. On the other side, in vitro and in vivo stud-
ies have confirmed that lactulose possesses patient- and dose-dependent prebiotic 
properties [35].
2.3 Sialyllactose
Sialyllactose (C23H39NO19; NeuAcα2-xD-galactopyranosyl-α-D-glucopyranoside; 
MW, 633.6 g/mol) is essentially sialic acid (N-acetylneuraminic acid, NeuAc) 
bound to a lactose molecule. This lactose-derived compound is naturally found 
in high concentrations at the beginning of lactation in colostrum and decreases 
towards the end of lactation [16]. The predominant forms of sialyllactose are 
6′-sialyllactose and 3′-sialyllactose. The concentrations of 6′-sialyllactose in human 
colostrum is 250–1300 mg/L, meanwhile the concentration of 3′-sialyllactose in 
bovine colostrum is 354–1250 mg/L [38]. These lactose-derived compounds are 
extracted from CW using ultra and nanofiltration processes on a tangential flow 
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type laboratory scale membrane filtration system [39]. Even though this still an 
expensive procedure to extract sialyllactose, some infant formulae use it as func-
tional ingredient [16, 40].
In vivo studies have demonstrated the ability of sialyllactose to improve posi-
tively in health. Pathogenic microorganisms have been effectively inhibited using 
it [16, 40]. It was reported that the consumption of dietary sialyllactose modified 
the colonic microbiota, e.g. Bacteroidetes were significantly increased, meanwhile 
Firmicutes and Cyanobacteria were significantly decreased. Moreover, this lactose-
derived prebiotic was able to diminish stressor-induced alterations in colonic 
mucosa and anxiety-like behavior [41]. One of the major causes of morbidity and 
mortality in premature infants is necrotizing enterocolitis (NEC). Recently, it was 
found that human milk oligosaccharides 2′-fucosyllactose and 6′-sialyllactose can 
reduce NEC and attenuate NEC inflammation [42]. In addition, intact sialylated 
oligosaccharides can be absorbed in concentrations high enough to modulate the 
immunological system and facilitate proper brain development during infancy [43].
3. Functional compounds bio-produced using lactose as substrate
3.1 Biocatalytic processes
3.1.1 Galacto-oligosaccharides
Galacto-oligosaccharides [Gal-(Gal)n-Glu] are lactose-derived non-digestable 
oligosaccharides (GOS) recognized as relevant functional compounds. Industrially, 
GOS are produced using CW lactose as substrate through biocatalytic reaction. 
Lactose is transgalactosylated by ß-galactosidases enzymes (E.C. 3.2.1.23) from sev-
eral microbial strains [44]. GOS are the best substitute for human oligosaccharides, 
have a sweet taste, low energy value (2 kcal/g), as well as tolerate high temperatures 
and low pHs. So, they are widely used in the food industry as functional ingredient 
in the manufacturing of infant formula, confectionary, chewing gum, yogurt, ice 
cream and bakery products [45].
Previous studies have demonstrated the impact of GOS promoting gut health 
and well-being. These lactose-derived prebiotics serve as substrates for the micro-
biota, improve saccharolytic metabolic activities and stimulate the growth of 
indigenous bifidobacteria and lactobacilli. In consequence, the formation of volatile 
fatty acids, lowering of the luminal pH and decreased formation of toxic secondary 
bile acids are microbial metabolic associated effects. Also, they inhibit the forma-
tion of toxic bacterial metabolites, such as ammonia, hydrogen disulphide, phenolic 
compounds and biogenic amines [44]. Moreover, GOS have a bifidus factor similar 
to the effect of human milk oligosaccharides stimulating the growth of specific 
intestinal microbiota, improving the intestinal motility, enhancing immunity, 
promoting the synthesis of vitamins, reducing the high levels of cholesterol and 
triglycerides and decreasing the risk of colon cancer development [45, 46].
3.1.2 Lactosucrose
Lactosucrose is an oligosaccharide comprising Gal, Fru and Glu. This carbohy-
drate molecule (C18H38O16; MW, 510.4 g/mol) is a ß-D-fructofuranosyl-4-O- ß-D-
galactopyranosyl-α-D-glucopyranoside [16]. Lactosucrose can be regarded as a 
condensate of sucrose and galactose molecules or lactose and fructose molecules. 
Production protocols include transferring the ß -galactosyl group produced by the 
decomposition of lactose to the C4 hydroxyl group of glucosyl in sucrose by the 
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enzymatic activity of ß-galactosidase (E.C. 3.2.1.23). Also, it can be produced by 
the catalysis of ß-fructofuranosidase (E.C. 3.2.1.26) or levansurase (E.C. 2.4.1.10) 
transferring the fructose group generated by the decomposition of sucrose to the C1 
hydroxyl group at the reducing end of the lactose. Industrially, ß-fructofuranosi-
dase is one of the most common enzymes used to the production of lactosucrose due 
to its availability and low cost [47]. This non-reducing trisaccharide is an ingredient 
of cosmetic and pharmaceutical products. Moreover, it is widely used in a large 
number of functional foods. In fact, in Japan, lactosucrose has the status of FOSHU 
ingredient. So, it has been used in a large number of healthy foods and drinks, 
such as bakery products, yogurt, ice creams, infant formula, chocolates, juice and 
mineral water [48].
In the last decades, the demand for lactosucrose has significantly increased. This 
can be explained by the widely uses of it in the preparation of functional foods. 
Lactosucrose is well known by its prebiotic effect. In vivo studies in animals, as well 
as in humans have demonstrated the association between lactosucrose consumption 
and health-promoting effects. Their review includes enhancement of beneficial 
bacteria and or inhibition of pathogenic microorganisms, decrease of fecal pH, 
production of short chain fatty acids and gases, reduction of putrefactive products, 
enhancement of intestinal absorption of minerals, treatment of chronic inflam-
matory bowel diseases, normalization of intestinal microflora and prevention of 
abdominal symptoms of lactose intolerance [48].
3.2 Microbial bioprocesses
3.2.1 Lactic acid bacteria exopolysaccharides (LAB-EPS)
Lactic acid bacteria (LAB) play a key role in the fermentation processes of food 
worldwide. These group of microorganisms improve the preservation, enhance 
sensory characteristics, increase nutritional values of a large variety of food and 
beverages products and have been recognized by their health-promoting attributes 
[49]. Several LAB have the ability to produce exopolysaccharides (EPS) as cell wall 
constituents named peptidoglycan located in the extracellular medium without 
covalent bounds with bacterial membrane [49, 50]. EPS are a diverse group of 
high-molecular-mass polysaccharides in terms of chemical composition, quantity, 
molecular size, charge, presence of side chains rigidity of the molecules, including 
mechanisms of synthesis [49, 51].
LAB-EPS are classified depending on the composition of the main chain and 
their mechanisms of synthesis. They can be divided into homopolysaccharides 
(HoPs) or heteropolysaccharides (HePs) In general, HoPs contain only one type 
of monosaccharide (glucose or fructose) through linear or branched α or β links, 
with more than 106 Da molecular mass. These EPS are produced in grams per 
liter by Lactobacillus, Leuconosctoc, Oenococcus and Weissella extracellularly from 
sucrose or starch without noncarbohydrate groups. On the other side, HePs contain 
more than one type of monosaccharide, mainly glucose, galactose and rhamnose 
together through α and β links, typically branched with 104–106 Da molecular mass. 
Most of them are produced in milligrams per liter by Lactobacillus, Lactococcus, 
Bifidobacterium and Streptococcus from intracellular intermediates with the presence 
of noncarbohydrates groups [51].
Kefiran is the main HePs synthetized by kefir grains microorganisms. Kefir 
grains are a consortium of symbiotic LAB, acetic acid bacteria, bifidobacteria and 
yeast microorganisms embedded in a matrix of proteins, lipids, polysaccharides 
and water [52] . These microorganisms are able to synthetize kefiran from CW 
lactose even if it is deproteinized [53]. In fact, using CW lactose as a fermentation 
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medium presents the opportunity to create value-added products [54]. Lactobacillus 
kefiranofaciens has been identified as the most important kefiran producer. Previous 
study demonstrated this extracellular polysaccharide is water soluble and it has the 
same amounts of D-glucose and D-galactose, approximately. Kefiran has several 
relevant applications within the biotechnology, food and pharmaceutical industries 
[52]. Therefore, increasing attention has been paid to these EPS.
Kefiran is a natural EPS that offers relevant food and pharmaceutical industrial 
advantages. It could be added to a formulation or it could be produced in situ 
through fermentation processes. As a polymer, kefiran exert versatile functionality. 
In food industry, for example it has widely applications such as stabilizer, additive, 
film-forming agent and gelling agent. In recent years, it has been discovered novel 
nano applications of this HePs, e.g. kefiran-based bio-nanocomposites and kefiran 
based nanofibers. Moreover, this bio-molecule also has shown biological activity 
properties. Several in vitro and in vivo studies have demonstrated the ability of 
kefiran to increase peritoneal IgA, reduce blood pressure induced hypertension, 
wound healing, antioxidant activity, antitumoral activity, favor the activity of peri-
toneal macrophages, modulation of the intestinal immune system and protection 
of epithelial cells against, prevent several cancer, anti-inflammatory and prebiotic 
effect [55, 56].
HoPs have also potential uses in the food and pharmaceutical industries. 
Fructans (levan and inulin-like), α -glucans (dextran, reuteran, alternan and 
mutan) and β -glucans are the most important HoPs [49, 51]. HoPs such as dextran 
have been using in bakery products improving softness or in confectionary, ice 
cream, frozen and dried-food and non-alcoholic wort-based beverages as sta-
bilser. Levan and inulin-like HoPs can be used as fat substitute and sugar replacer, 
respectively. Besides, these HoPs may influence human host health. For example, 
β-glucans have demonstrated a cholesterol-lowering effect increasing cardiovas-
cular health. Moreover, Lactobacillus delbrueckii subsp. bulgaricus strains HoPs 
removed cholesterol from in vitro culture media. Indeed, HoPs have been recog-
nized by their benefits on the microbial gut modulation acting as prebiotics [51].
3.2.2 Mushrooms
In recent years, the use of CW for mycelial growth has been explored. CW as 
substrate offers a wide diversity of nutrients such as proteins, carbohydrates, lipids, 
vitamins and minerals. On the other side, the metabolism of mycelia of fungi pro-
duced edible mushrooms utilizes the nutrients from the medium to bioaccumulate 
microelements such as Se, Fe and Zn. Therefore, the use of CW for mycelial growth 
may be a valuable nutritional supplement, reducing the impact of discharging CW 
to the environment and biofortifies mushrooms composition.
The nutritional, culinary and nutraceutical properties of mushrooms have 
attracted the researchers, pharmacists and nutritionists attention. The chemical 
composition of mushrooms includes bioactive molecules such as polysaccharides, 
terpenoids, low molecular weight proteins, glycoproteins among others that play 
a key role in boosting immune strength, lowering risks of cancers, inhibiting of 
tumoral growth, maintaining of blood sugar, etc. [57].
Information on mushrooms chemical composition, nutritional value and 
therapeutic properties has expanded during the last few years. Pleurotus spp. 
(oyster mushrooms) are one of the most cultivated mushrooms worldwide [58]. 
Recently, it was demonstrated that the mycelial growth of Pleurotus djamor in a 
liquid culture medium containing CW was able to produce bioactive compounds 
such as ergosterol and β-glucans. The addition of selenium to the medium decreased 
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the concentration of lactose. Moreover, it was observed that the mycelium showed 
potential in absorbing and accumulating elements e.g. Ca, Fe, Mg, K and Zn from 
the CW [59].
3.2.3 Organic acids
Several organic acids are produced during the metabolic pathways of the fer-
mentation processes. Some organic acids e. g. lactic acid, propionic acid, butyric  
acid, isobutyric acid, acetic acid, capric acid, caproic acid, caprylic acid, lactobi-
onic acid, etc., are responsible for characteristic flavors [60, 61]. However, they 
play a key role as functional compounds enhancing health-promoting effects and 
well-being. It has been demonstrated that conjugated linoleic acid (CLA, 9,11- 
Octadecadienoic acid, MW, 280.4 g/mol) modulate the fatty acid composition of 
the liver and adipose tissue of the host [62]. Indeed, succinic acid (C4H6O4, MW, 
118.09 g/mol) has shown its ability to stabilize the hypoxia and cellular stress 
conditions focusing on the maintenance of homeostasis in aging hypothalamus. 
Therefore, it is hypothesized that succinate has the potential to restore the loss in 
functions associated with cellular senescence and systematic aging [63]. Most of the 
commercial succinic acid production is done by chemical technologies like catalytic 
hydrogenation or electrolytic reduction of maleic anhydride. In the last years, it was 
found that it can be produced using CW and lactose as substrates by Actinobacillus 
succinogenes 130Z in a batch fermentation [64].
According to the international market demands, lactobionic acid, fumaric 
acid and glucaric acid are classified as high value-added compounds [61]. These 
organic acids have demonstrated potential uses in food, medicine, pharmaceuti-
cal, cosmetic and chemical industries [61, 65, 66]. Glucaric acid (C6H10O8, MW, 
210.14 g/mol) is found in vegetables and fruits, mainly grapefruits, apples, oranges 
and cruciferous vegetables. Commercially, it is synthetized by chemical oxidation 
of glucose releasing toxic byproducts. Thus, microbial fermentation of glucose by 
Saccharomyces cerevisiae and Escherichia coli has been proposed as alternative. This 
organic acid and its derivatives increases detoxification of carcinogens compounds 
and tumor promoters [67, 68]. Fumaric acid (trans-1,2-ethylenedicarboxylic acid, 
MW, 116.07 g/mol) is traditionally synthetized from maleic anhydride, which in 
turn is produced from butane. Nowadays, the production of this organic acid may 
be done by fermenting glucose through the metabolic pathways of Rhizopus species, 
also fixing CO2. Fumaric acid is widely used as starting material for polymerization 
and esterification reactions to produce paper and unsaturated polyester resins. In 
medicine field, it can be used to treat psoriasis, meanwhile it is also used as food and 
beverage additive. Moreover, Fumaric acid supplements have the ability to reduce 
methane emissions of cattle [66].
Lactobionic acid (4-O-ß -galactopyranosyl-D-gluconic acid, MW, 358.3 g/mol) 
is a high value-added lactose derivative. This organic acid has received growing 
attention due to its multiple applications in cosmetics, chemical, pharmaceutical, 
biomedicine, and food industries [61]. Lactobionic acid production is based on 
chemical synthesis requiring high amounts of energy and costly metal catalysts 
[69]. Nowadays, lactobionic acid is able to be bio-produced either through enzy-
matic or microbial biosynthesis at cost-effective and environmentally friendly 
using cheese whey lactose. In fact, high-level production of it has been recently 
reported controlling pH and temperature during the fermentation of lactose with 
Pseudomonas taetrolens [70]. Lactobionic acid offers wide versatile uses in nano-
technology, tissue engineering and drug-delivery systems, antibiotics, preservative 
solutions for organ transplantation, anti-aging, regenerative skin-care, sugar-based 
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surfactant. Also, this value-added compound functions as food additive, gelling 
agent, solubilizing agent, sweetener, water holding capacity agent and bioactive 
ingredient enhancing calcium absorption, antioxidant activity and exerting prebi-
otic effects [61].
Lactic acid (2-hydroxipropionic acid, MW 90.08 g/mol) is an organic acid 
with a prime position due to its versatile applications in textile, leather, chemical, 
pharmaceutical and food industries. Lactic acid applications associated to food and 
food-related represent 85% of total production, approximately. This organic acid 
has been recognized as GRAS by the FDA [71]. It is used as flavoring, buffering 
agent, inhibitor of bacterial spoilage, acidulant, dough conditioner and emulsi-
fier [72]. Most of lactic acid is produced through microbial fermentation, mainly 
Lactobacillus delbrueckii or Lactobacillus amylophilus strains, using beet extracts, 
molasses, starchy and cellulosic materials and cheese whey [71].
Polylactic acid is a biocompatible polymer with unique properties. Lactic acid 
and lactide are the building blocks to obtain it through a polycondensation reaction. 
This biodegradable and renewable biopolymer is a relevant alternative to plastics 
derived from petrochemicals, so its demand has been increasing considerably. In 
fact, the global polylactic acid market was expected to grow over 1.2 million tons in 
2020. Nowadays, most polylactic acid is manufactured for single-use applications 
in packaging, including food packaging supplies [73]. However, it has important 
biomedical uses, due to its GRAS status recognized by the FDA. This biomaterial 
has been transformed into sutures, scaffolds, cell carriers and drug delivery systems 
such as liposomes, polymeric nanoparticles, dendrimers and micelles [74, 75].
4. Conclusions
Cheese whey production is increasing worldwide every year. Even though CW 
is considered a major environmental pollutant, due to its quantity and quality 
of chemical components, there is a huge opportunity to use it as raw material to 
produce value-added functional compounds. CW lactose is an excellent substrate 
to obtain high quality products able to improve human health and well-being, e.g. 
lactitol, lactosucrose, GOS, lactulose, sialyllactose and organic acids. For example, 
GOS and sialyllactose have a bifidus factor similar to the effect of human milk 
oligosaccharides stimulating the growth of specific intestinal microbiota, enhanc-
ing immunity, promoting the synthesis of vitamins and decreasing the risk of colon 
cancer. Moreover, microbial bioprocesses use CW lactose to produce relevant health-
promoting metabolites such as kefiran and organic acids. Future perspectives are 
focusing on the sustainable transformation of CW lactose as by product into value-
added functional compounds to be used as novel ingredients in a diverse formulation 
of food, pharmaceutical, and cosmetic new products. Therefore, additional research 
concentrated on the development of innovative technological processes, more 
efficient and able to discover new bioactive compounds are essential.
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